Shop

Covid Antigen Test Kits

500.00 inc. VAT @23%

SOLD in Boxes of 20 tests

The MEXACARE Coronavirus Antigen Rapid Test is a rapid chromatographic immunoassay for the qualitative detection of SARS-CoV-2 antigens present in the human nasopharynx. One antigen (protein of COVID-19) is usually detectable in upper respiratory tract samples during the acute phase of infection. Positive results indicate the presence of viral antigens.

Relative Sensitivity 95.65% (95 % CI*: 91.9 %-99.4%)
Relative Specificity 99.38% (95 % CI*: 98.5%->99.9%)
Accuracy 98.39% (95 % CI*: 97.2%-99.57%)

The benefits of the MEXACARE COVID-19 Antigen Rapid Test

• Very high sensitivity (>93 %) and specificity (>98 %)

• Fast availability of test results (approx. 15 minutes)

• No expensive laboratory equipment needed

• No additional reagents required

• All materials for direct on-site testing included (Point-of-Care)

• No need to transport samples to the laboratory

 

Download Mexacare rapid test  Data Sheet

 

SOLD in Boxes of 20 tests

 

SKU: 007-1-1 Categories: , ,
Additional Information
Weight 0.01 kg
When should I test with the MEXACARE COVID-19 Antigen Rapid Test

When should I test with the MEXACARE COVID-19 Antigen Rapid Test
Like the RT-PCR test. which is currently the gold standard. an antigen test is able to detect infection with
the novel coronavirus SARS-CoV 2 very early after infection.
In the earliest stages of the disease – during the incubation period (according to the WHO an average of
5-6 days) and in the first 2-3 days after the onset of symptoms. a test with the MEXACARE COVID-19
Antigen Rapid Test is therefore recommended. Since the test detects protein components of the actual
virus (so-called antigens) and not antibodies (the immune reaction of the human body against the virus).
acute infections with SARS-CoV-2 can be detected at this early stage.

How well does

The MEXACARE COVID-19 Antigen Rapid Test perform at different Ct values?
In order to determine the sensitivity of the COVID-19 Antigen Rapid Test at different Ct values, MEXACARE
conducted a comparative study with patient samples in Austria that were confirmed positive by RT-PCR
(including determination of the Ct value). In this study the MEXACARE COVID-19 Antigen Rapid Test
achieved the following results:
RT-PCR Ct-values Sensitivity of MEXACARE
Covid-19 Antigen Rapid Test

20-30 100 %
20-31 96.2 %
20-32 96.3 %
20-33 90.0 %
20-34 90.3 %